![]()
Adds PL, PN statements
Some 110 employees at Arrow Pharm in Hal Far are at risk of redundancy as a result of restructuring, mother company Actavis announced this morning.
Economy Minister Chris Cardona said as the news was made public that the government was committed to finding the workers an alternative job.
Activis said in a statement that: "Following the acquisition of Actavis by Watson Pharmaceuticals (now Actavis plc) in 2012, the company has been addressing over capacity and overlaps in its global operations. The announcement of the intention to restructure is part of the continued integration of the two global companies.
"The restructuring is due primarily to a 50% reduction in packaging volumes at the facility, as well as a drive to make the Hal Far site more cost competitive in the face of aggressive global competition within the industry," the company said.
"The company regrets to inform that approximately 110 employees in the Arrow Pharma facility are at risk of redundancy, as a result of the restructuring. The company is eager to minimise the number of employees impacted, through the possible inclusion of a number of Hal Far employees within any potential...